A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants.
The effects of dietary docosahexaenoic acid (DHA) supply during infancy on later cognitive development of healthy term infants were evaluated in a randomized clinical trial of infant formula milk supplemented with 0.35% DHA or with 0.36% DHA and 0.72% arachidonic acid (AA), or control formula which provided no DHA or AA. Fifty-six 18-month-old children (26 male, 30 female) who were enrolled in the trial within the first 5 days of life and fed the assigned diet to 17 weeks of age were tested using the Bayley Scales of Infant Development, 2nd edition (BSID-II) (Bayley 1993) at the Retina Foundation of the Southwest, Dallas, TX. These children had also been assessed at 4 months and 12 months of age for blood fatty-acid composition, sweep visual evoked potential (VEP) acuity, and forced-choice preferential looking (FPL) acuity (Birch et al. 1998). Supplementation of infant formula with DHA+AA was associated with a mean increase of 7 points on the Mental Development Index (MDI) of the BSID-II. Both the cognitive and motor subscales of the MDI showed a significant developmental age advantage for DHA- and DHA+AA-supplemented groups over the control group. While a similar trend was found for the language subscale, it did not reach statistical significance. Neither the Psychomotor Development Index nor the Behavior Rating Scale of the BSID-II showed significant differences among diet groups, consistent with a specific advantage of DHA supplementation on mental development. Significant correlations between plasma and RBC-DHA at 4 months of age but not at 12 months of age and MDI at 18 months of age suggest that early dietary supply of DHA was a major dietary determinant of improved performance on the MDI.
Birch
E E
EE
Retina Foundation of the Southwest, Dallas, TX 75231, USA. ebirch@retinafoundation.org
Garfield
S
S
Hoffman
D R
DR
Uauy
R
R
Birch
D G
DG
D000704:Analysis of Variance; D016718:Arachidonic Acid / Q000008:administration & dosage*; D002657:Child Development / Q000502:physiology; D003071:Cognition / Q000502:physiology*; D004281:Docosahexaenoic Acids / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D007225:Infant Food; D008055:Lipids / Q000097:blood; D008297:Male; D009048:Motor Skills / Q000502:physiology; D018709:Statistics, Nonparametric; D014792:Visual Acuity / Q000502:physiology
D008055:Lipids; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid